# Maternal Immunization With MenAfriVac™

> **NCT03746665** · PHASE3 · UNKNOWN · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 200 (estimated)

## Conditions studied

- Meningitis
- Meningococcal

## Interventions

- **BIOLOGICAL:** meningococcal serogroup A conjugate vaccine

## Key facts

- **NCT ID:** NCT03746665
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-19
- **Primary completion:** 2020-10-12
- **Final completion:** 2021-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-01-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03746665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03746665, "Maternal Immunization With MenAfriVac™". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03746665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*